Sort
39,280 grants matching “leukemia”
Tumor Microenvironment in Cancer Progression
$1,116,420Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular Basis for the Pathogenesis of Murine Retroviruses
$1,115,988Sandra K Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Apoptosis-Based Cancer Drug Discovery
$1,115,725John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U19 · FY2009 · CA
Cancer and Leukemia Group B Human Specimen Repositories
$1,114,720Richard L Schilsky · University Of Chicago · U24 · FY2008 · CA
Integrase
$1,113,302Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Cancer and Leukemia Group B Human Specimen Repositories
$1,113,115University Of Chicago · U24 · FY2005 · CA
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
$1,113,000Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R35 · FY2023 · HL
Apoptosis-Based Cancer Drug Discovery
$1,112,625John C Reed · Sanford Burnham Prebys Medical Discovery Institute · U19 · FY2008 · CA
Telomere Diseases
$1,112,403Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$1,110,653Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$1,110,488Sankar Adhya · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Improved Chimeric Antigen Receptor Therapies B-cell Malignancies
$1,110,078James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,810Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2021 · CA
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
$1,109,637Jeffrey Wallace Tyner · Oregon Health & Science University · U01 · FY2024 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,109,082Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2022 · CA
Clinical Trials with Immunotoxins
$1,108,096Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Host Defense Regulation and Viral Oncogenesis
$1,107,550Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2011 · CA
Eliminating Interference from Autofluorescence in Flow Cytometry
$1,107,310Giacomo Vacca · Kinetic River Corporation · R44 · FY2023 · GM
Clinical and translational studies of RUNX1 and FPDMM
$1,106,669Paul Liu · National Human Genome Research Institute · ZIA · FY2021 · HG
Mechanistic and translational studies of CBF leukemia
$1,106,669Paul Liu · National Human Genome Research Institute · ZIA · FY2021 · HG
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,106,459Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2023 · CA
PATHOGENESIS OF PERSISTENT VIRAL INJURY TO THE CNS
$1,106,398University Of Pennsylvania · P01 · FY2002 · NS
ONCOGENES IN CANCER ETIOLOGY AND PROGRESSION
$1,106,271Thomas Jefferson University · P01 · FY2000 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,105,926Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
MOUSE MODELS OF MYELOID LEUKEMIA
$1,105,106University Of California San Francisco · U01 · FY2003 · CA